International Journal of Clinical Research

Objective: To analyze the clinical characteristics and treatment of pulmonary tuberculosis with multiple serous cavity effusion. Methods: from May 2021 to may 2022 in our hospital, 34 patients with pulmonary tuberculosis combined with multiple serous cavity effusion were randomly selected for retrospective study. Clinical diagnosis was carried out on the above patients, and 17 of them were treated with HREZV combined with hormone, which was recorded as the observation group, and the other 17 were treated with conventional HREZ anti tuberculosis, which was recorded as the comparison group. The treatment situation of the two groups of patients was compared. Results: the treatment efficiency, recovery of lung function and improvement of blood gas indexes in the observation group were significantly better than those in the control group (P < 0.05). Conclusion: the patients with pulmonary tuberculosis complicated with multiple serous cavity effusion are mainly manifested as infiltrative pulmonary tuberculosis and acute hematogenous disseminated pulmonary tuberculosis in clinic. The incidence position is both unilateral and multi lateral. The effect of quadruple antituberculosis treatment is significantly better than that of conventional antituberculosis treatment, and the clinical symptoms are improved.

Pulmonary Tuberculosis; Multiple Serous Cavity Effusion; Clinical Characteristics; Treatment Methods; Complication